Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 12.50 |
Expiry date | 2024-06-21 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 6 |
Amidst a backdrop of economic cooling and fluctuating market conditions, the U.S. stock market has shown resilience with signs that rate cuts could be on the horizon, potentially buoying investor sentiment. In this context, companies with high insider ownership can be particularly compelling as they often signal strong confidence from those closest to the company's operations and future prospects.
Theravance Biopharma ( NASDAQ:TBPH ) First Quarter 2024 Results Key Financial Results Revenue: US$14.5m (up 39% from 1Q...
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.